Swiss government launches Covid-19 scientific taskforce
The federal authorities have set up a scientific taskforce to advise the Federal Council and to coordinate national research by universities into coronavirus.
This content was published on
2 minutes
Keystone-SDA/sb
Português
pt
Governo suíço lança força-tarefa contra a Covid-19
The “Covid-19 taskforce” will be led by Matthias Egger, president of the national research council of the Swiss National Science Foundation (SNSF), the government announcedExternal link on Tuesday.
The group will advise the government, interior ministry and other relevant federal and cantonal authorities. It will also identify areas of research and special measures or products that the Swiss scientific community could rapidly contribute to global efforts to fight the virus.
“The Swiss scientific community offers huge potential to have a positive influence on the outcome of the crisis via research, training or knowledge transfer,” the interior ministry said.
It will aim to coordinate coronavirus research being done into diagnostic tests, healthcare, clinical research and contact-tracing via new digital applications, as well as related ethical and legal issues.
More
More
What Swiss researchers are doing to beat Covid-19
This content was published on
Swiss scientists and drug companies are playing an important role in the global effort to develop treatments or a vaccine for the virus.
The taskforce will build on a call by the SNSF on February 25 for proposals on research into coronaviruses “to tackle the current crisis and prepare for future likely epidemics”. A sum of CHF5 million ($5.2 million) has been earmarked for projects.
The SNSF has received 270 applications, according to Swiss public radio, RTS, on Tuesday. The majority of projects were biomedical, including studies of viruses and infections, the immune response in humans and the spread of the disease.
The selected projects “will provide a basis for the subsequent industrial development of active agents”. The grants available are CHF50,000-CHF300,000 per project.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
University students in Switzerland join Gaza protest wave
This content was published on
Pro-Palestinian activists occupied university buildings in Lausanne, Geneva and Zurich on Tuesday, widening the protest movement in the Alpine nation.
TradeXBank to resume full operations after Sberbank Switzerland taken off sanctions list
This content was published on
TradeXBank, the former Swiss branch of Russia’s Sberbank, will be able to resume its dollar-denominated activities from the second half of this year.
Geneva decides not to remove controversial memorials
This content was published on
The city of Geneva has presented an action plan regarding a series of controversial local statues and monuments of historical figures linked to racism, colonialism or slavery.
University of Lausanne calls for end to pro-Palestine sit-in
This content was published on
The pro-Palestinian occupation continues at the University of Lausanne (UNIL). On Monday evening, a group of students refused to agree to the deadline set by the rectorate.
Ukraine peace conference should include Russia, says Chinese ambassador
This content was published on
China supports a peace conference on the Ukraine war that would see equal participation of all parties, says Chinese Ambassador to Russia Zhang Hanhui.
This content was published on
A majority of Swiss citizens have open attitudes towards various infertility treatments, including even egg donation, which is currently prohibited.
Reports of Swiss cyber fraud almost doubled in six months
This content was published on
The head of the new Federal Office for Cybersecurity (FOC), Florian Schütz, has presented a new strategy after just over four months in office.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
What Swiss researchers are doing to beat Covid-19
This content was published on
Swiss scientists and drug companies are playing an important role in the global effort to develop treatments or a vaccine for the virus.
‘Anti-malaria drug can kill coronavirus’: Novartis chief
This content was published on
Swiss pharmaceutical giant Novartis believes the anti-malaria drug hydroxychloroquine offers one of the best hopes to combat coronavirus.
Covid-19 immunity testing to begin in some Swiss hospitals
This content was published on
The hospitals are planning to roll out testing to evaluate how many people have already been infected, including those who may have already be immune.
Global cooperation needed to prevent Covid-19 drugs ‘free-for-all’
This content was published on
Weaker countries may be pushed aside in the scramble for effective drugs to fight coronavirus, an infectious diseases expert fears.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.